🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522914-22-00
Completed Phase I

A Study of JNJ-90301900 in Combination with Concurrent Chemoradiation Therapy in LA HNSCC

2025-522914-22-00 · tracked via the Priya Life Science EU tracker
Sponsor
Janssen Cilag International
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
02/02/2026
Enrollment target
16
Sites
France, Spain

Condition studied

Locally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522914-22-00 on CTIS ↗ ← All trials in the EU